The COASY Gene Neurodegeneration with Brain Iron Accumulation Type 6 (NBIA6) genetic test is a specialized diagnostic tool used to identify mutations in the COASY gene, which are linked to a rare form of neurodegeneration characterized by the accumulation of iron in the brain. This condition, known as NBIA6, can lead to a range of neurological symptoms, including movement disorders, psychiatric issues, and progressive deterioration of motor functions. The test is crucial for confirming a diagnosis, enabling early intervention, and facilitating appropriate management and treatment strategies for affected individuals.
Conducted at DNA Labs UAE, the test involves a detailed analysis of the patient's DNA to detect any abnormalities or mutations in the COASY gene that could indicate the presence of NBIA6. This state-of-the-art genetic testing provides families and healthcare professionals with essential information regarding the genetic basis of the condition, helping to guide treatment decisions and offering insights into potential genetic counseling needs for the family.
The cost of the COASY Gene Neurodegeneration with Brain Iron Accumulation Type 6 Genetic Test at DNA Labs UAE is 4400 AED. Given the specialized nature of the test and the expertise required to accurately interpret the results, this cost reflects the comprehensive analysis and personalized care that patients receive. For families facing the challenges of NBIA6, this test represents a critical step towards understanding and managing the condition more effectively.
The MYOT gene myotilinopathy genetic test is a specialized diagnostic tool designed to identify mutations in the MYOT gene, which are linked to the development of myotilinopathy, a rare form of muscular dystrophy. This condition is characterized by muscle weakness and atrophy, primarily affecting the skeletal muscles. Early diagnosis through this genetic test can be crucial for managing symptoms, implementing appropriate treatment plans, and understanding the inheritance pattern within affected families.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to detect specific genetic alterations in the MYOT gene that are responsible for the condition. The process is comprehensive, ensuring high accuracy and reliability in the results.
The cost of the MYOT gene myotilinopathy genetic test at DNA Labs UAE is set at 4400 AED. While the price might seem significant, the value of obtaining a precise diagnosis cannot be understated, as it opens the door to targeted therapies and interventions, potentially improving the quality of life for individuals with myotilinopathy.
The DMPK Gene Myotonic Dystrophy Type 1 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the DMPK gene, which are responsible for causing Myotonic Dystrophy Type 1 (DM1). This condition is characterized by progressive muscle loss and weakness, myotonia, and various other systemic issues. The test involves analyzing the patient's DNA to identify the specific genetic alteration within the DMPK gene, known as a CTG triplet repeat expansion. The presence and size of the expansion can help in confirming the diagnosis of DM1 and predicting the severity of the condition.
Offered by DNA Labs UAE, this genetic test is a critical tool for individuals suspected of having Myotonic Dystrophy Type 1 or for those with a family history of the disease, aiming to provide a clear genetic diagnosis. The test is priced at 4400 AED and is conducted in a state-of-the-art laboratory setting, ensuring high accuracy and reliability of the results. Through this test, patients and their families can gain valuable insights into the genetic basis of the condition, which can significantly aid in managing the disease and planning for the future.
The CNBP Gene Myotonic Dystrophy Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CNBP gene, which are responsible for causing Myotonic Dystrophy Type 2 (DM2). DM2 is a form of muscular dystrophy that affects muscle function and can lead to a range of symptoms from myotonia, muscle weakness, cataracts, to heart problems. This genetic test is crucial for individuals with a family history of DM2 or those exhibiting symptoms, as it provides definitive diagnosis, allowing for appropriate management and treatment plans to be established. The test is priced at 4400 AED and involves a detailed analysis of the patient's DNA to detect the specific genetic mutation associated with the condition. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant step forward in the personalized care and management of patients with Myotonic Dystrophy Type 2.
The MTM1 Gene Myotubular Myopathy X-Linked Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the MTM1 gene, which are responsible for causing X-linked myotubular myopathy (XLMTM). This rare, inherited disorder primarily affects skeletal muscles, leading to muscle weakness, respiratory difficulties, and in severe cases, early mortality. The condition predominantly affects males due to its X-linked inheritance pattern.
Given the critical nature of early diagnosis for managing symptoms and planning treatment strategies, this genetic test plays a vital role in identifying affected individuals. The test involves analyzing the patient's DNA to detect any abnormalities in the MTM1 gene, which provides instructions for producing myotubularin, a protein essential for muscle cell function.
The cost of the MTM1 Gene Myotubular Myopathy X-Linked Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the testing, including the sophisticated techniques used to accurately identify gene mutations and the professional expertise required to interpret the results. Undergoing this test at DNA Labs UAE ensures access to cutting-edge genetic testing technology, along with support from experienced genetic counselors who can provide valuable insights into the implications of the test results for the patient and their family.
The HCRT Gene Narcolepsy Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the hypocretin (orexin) receptor 2 gene (HCRT), which are strongly associated with the development of narcolepsy. Narcolepsy is a chronic sleep disorder characterized by overwhelming daytime drowsiness and sudden attacks of sleep, often leading to significant disruptions in daily life. This genetic test plays a crucial role in the early detection and diagnosis of narcolepsy, allowing for timely intervention and management of the condition.
Performed in the state-of-the-art facilities of DNA Labs UAE, the test requires a simple blood sample from the patient. The sample is then analyzed for specific genetic markers that indicate a predisposition to narcolepsy. The process is highly accurate, leveraging advanced genetic sequencing techniques to ensure reliable results.
The cost of the HCRT Gene Narcolepsy Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of early detection and the potential for improved quality of life through personalized treatment plans make it a worthwhile investment for individuals experiencing symptoms of narcolepsy or those with a family history of the disorder.
The TPM3 Gene Nemaline Myopathy Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the TPM3 gene, which are known to cause Nemaline Myopathy Type 1. This condition is a rare genetic disorder characterized by muscle weakness, hypotonia, and the presence of rod-like structures in muscle cells, which can affect individuals from infancy or childhood, leading to difficulties in walking, feeding, and breathing. The test involves analyzing the patient's DNA to detect any abnormalities in the TPM3 gene, providing crucial information for accurate diagnosis, management, and understanding of the disorder's progression. The cost of the test is set at 4400 AED, reflecting the intricate processes and advanced technology employed to ensure precise and reliable results. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures that patients receive comprehensive support throughout the testing process, from sample collection to result interpretation, aiding in the better management of Nemaline Myopathy Type 1.
The NEB Gene Nemaline Myopathy Type 2 Autosomal Recessive Genetic Test is a specialized diagnostic examination designed to detect mutations in the NEB gene, which are responsible for causing Nemaline Myopathy Type 2 (NEM2). Nemaline Myopathy is a genetic muscle disorder characterized by muscle weakness, hypotonia, and the presence of rod-like structures in muscle cells, affecting individuals from infancy or early childhood. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
This genetic test is crucial for the accurate diagnosis of Nemaline Myopathy Type 2, enabling healthcare professionals to provide appropriate management and treatment options for affected individuals. It involves the collection of a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the NEB gene.
Performed at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates, the test ensures high accuracy and reliability. The cost of the NEB Gene Nemaline Myopathy Type 2 Autosomal Recessive Genetic Test is 4400 AED. Opting for this test at DNA Labs UAE offers individuals and families the advantage of accessing cutting-edge genetic testing technologies, expert interpretation of results, and comprehensive support throughout the testing process.
The TPM2 Gene Nemaline Myopathy Type 4 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the TPM2 gene, which are associated with Nemaline Myopathy Type 4. Nemaline Myopathy is a genetic disorder characterized by muscle weakness, hypotonia, and the presence of rod-like structures called nemaline bodies in muscle fibers, visible under a microscope. The condition is part of a broader group of neuromuscular disorders that can vary in severity and onset, with some forms present from birth.
The TPM2 gene plays a crucial role in muscle function and structure, encoding a protein essential for muscle fiber stability and contraction. Mutations in this gene can disrupt normal muscle function, leading to the symptoms observed in Nemaline Myopathy Type 4.
The genetic test at DNA Labs UAE involves analyzing the patient's DNA, extracted from a blood sample, to detect mutations in the TPM2 gene. This test is vital for confirming the diagnosis of Nemaline Myopathy Type 4, allowing for a better understanding of the condition's prognosis, and informing treatment and management decisions. It is also useful for genetic counseling, helping families understand the risk of the disorder being passed on to future generations.
The cost of the TPM2 Gene Nemaline Myopathy Type 4 Genetic Test at DNA Labs UAE is 3200 AED. The test is conducted in a state-of-the-art laboratory by experienced geneticists and technicians, ensuring accurate and reliable results.
The KBTBD13 Gene Nemaline Myopathy Type 6 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the KBTBD13 gene, which are responsible for causing Nemaline Myopathy Type 6. This rare genetic disorder is characterized by muscle weakness, hypotonia, and the presence of rod-like structures in muscle cells, known as nemaline bodies. Early diagnosis through this genetic test is crucial for managing symptoms and improving the quality of life for affected individuals. The test is priced at 4400 AED and is conducted in the advanced facilities of DNA Labs UAE, ensuring accurate and reliable results. By analyzing a small sample of the patient's DNA, this test provides valuable information for genetic counseling and guides decision-making regarding treatment options.
